ARCHIVED: Appendix 3: The Management of the National Antiviral Stockpile: Options Report - Paediatric Oseltamivir Dosage Estimates, by Weight
Appendix 3: Paediatric Oseltamivir Dosage Estimates, by Weigh
| Body Weight in kg | Body Weight in lbs | Recommended Dose for 5 Days |
|---|---|---|
| ≤ 15 kg | ≤ 33 lbs | 30 mg twice daily |
| > 15 kg to 23 kg | > 33 lbs to 51 lbs | 45 mg twice daily |
| > 23 kg to 40 kg | > 51 lbs to 88 lbs | 60 mg twice daily |
| > 40 kg | > 88 lbs | 75 mg twice daily |
| Sources: National 50th percentile weight source of data: CDC website (as recommended by Canadian Paediatric Society) For information on specific dosages of zanamivir and amantadine for adults and children, refer to CPIP (Annex E) |
||||||||||||||
| Unit | Age in years | |||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | 2 | 3 | 4 | 5 | 6 | 7 | 8 | 9 | 10 | 11 | 12 | |||
| Paediatric Population (Canada - 2005) | total | 339,211 | 338,040 | 337,695 | 346,343 | 359,460 | 362,873 | 372,514 | 385,575 | 401,848 | 409,311 | 411,434 | 419,295 | |
| 50th percentile weight | kg | males | 10.3 | 12.7 | 14.4 | 16.3 | 18.5 | 20.8 | 23.2 | 25.8 | 28.7 | 32.1 | 36.1 | 40.7 |
| kg | females | 9.5 | 12.1 | 13.9 | 15.9 | 18 | 20.3 | 22.9 | 25.8 | 29.1 | 33.1 | 37.4 | 41.8 | |
| Weight range | kg | <15 | <15 | <15 | >15-23 | >15-23 | >15-23 | >23-40 | >23-40 | >23-40 | >23-40 | >23-40 | ||
| Recommended dose by weight | mg | 30 | 30 | 30 | 45 | 45 | 45 | 60 | 60 | 60 | 60 | 60 | adult dose | |
Page details
- Date modified: